Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
Author Department
Medicine
Document Type
Article, Peer-reviewed
Publication Date
4-1-2003
Recommended Citation
Irbesartan Diabetic, Nephropathy Trial., Collaborative Study, Group.(Braden GL). Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 2003 Apr;138(7):542-9.
COinS